Soluble CD23 and interleukin-1 receptor antagonist in human asthmatics following antigen challenge.
about
Expression of ADAMs and their inhibitors in sputum from patients with asthma.Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study.Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome.
P2860
Soluble CD23 and interleukin-1 receptor antagonist in human asthmatics following antigen challenge.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Soluble CD23 and interleukin-1 ...... s following antigen challenge.
@en
Soluble CD23 and interleukin-1 ...... s following antigen challenge.
@nl
type
label
Soluble CD23 and interleukin-1 ...... s following antigen challenge.
@en
Soluble CD23 and interleukin-1 ...... s following antigen challenge.
@nl
prefLabel
Soluble CD23 and interleukin-1 ...... s following antigen challenge.
@en
Soluble CD23 and interleukin-1 ...... s following antigen challenge.
@nl
P2093
P2860
P356
P1433
P1476
Soluble CD23 and interleukin-1 ...... s following antigen challenge.
@en
P2093
David D Hagaman
David J Amrol
James R Sheller
John J Murray
P2860
P356
10.1081/JAS-200044761
P407
P577
2005-02-01T00:00:00Z